References
- WindeckerSKolhPAlfonsoF2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Eur Heart J201435372541261925173339
- HeestermansAAvan WerkumJWTaubertDImpaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarctionThromb Res2008122677678118455217
- AlexopoulosDXanthopoulouIGkizasVRandomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarctionCirc Cardiovasc Interv20125679780423169985
- DorlerJEdlingerMAlberHFClopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarctionEur Heart J201132232954296121920970
- KoulSSmithJGScherstenFJamesSLagerqvistBErlingeDEffect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionEur Heart J201132232989299721719452
- Bellemain-AppaixAO’ConnorSASilvainJAssociation of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysisJAMA2012308232507251623287889
- MontalescotGvan’t HofAWLapostolleFPrehospital ticagrelor in ST-segment elevation myocardial infarctionN Engl J Med2014371111016102725175921
- ClemmensenPGriecoNInceHMULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel–the European MULTIPRAC RegistryEur Heart J Acute Cardiovasc Care20154322022925182465
- KoshyABalasubramaniamKNomanAZamanAGAntiplatelet therapy in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a retrospective observational study of prasugrel and clopidogrelCardiovasc Ther20143211624428852
- MehranRPocockSNikolskyEImpact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trialsJACC Cardiovasc Interv20114665466421700252
- WiviottSDBraunwaldEMcCabeCHPrasugrel versus clopidogrel in patients with acute coronary syndromesN Engl J Med2007357202001201517982182
- MurphySAAntmanEMWiviottSDReduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trialEur Heart J200829202473247918682445
- WiviottSDDesaiNMurphySAEfficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agenciesAm J Cardiol20111108790591121816379
- KurzDJRadovanovicDSeifertBComparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus RegistryEur Heart J Acute Cardiovasc Care201651132225614494
- KlingenbergRHegDRaberLSafety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in SwitzerlandHeart20151011185486325794517
- DammanPVarenhorstCKoulSTreatment patterns and outcomes in patients undergoing percutaneous coronary intervention treated with prasugrel or clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR])Am J Cardiol20141131646924169009
- WallentinLBeckerRCBudajATicagrelor versus clopidogrel in patients with acute coronary syndromesN Engl J Med2009361111045105719717846
- UdellJABraunwaldEAntmanEMMurphySAMontalescotGWiviottSDPrasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38)JACC Cardiovasc Interv20147660461224947719
- StegPGJamesSHarringtonRATicagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysisCirculation2010122212131214121060072
- StegPFirst Presentation of the PLATO Primary PCI SubgroupLecture presented at: Transcatheter Cardiovascular Therapeutics (TCT) conferenceSeptember 12, 2014Washington DC, USA Available from: http://www.tctmd.com/show.aspx?id=126403Accessed March 1, 2016
- MontalescotGBologneseLDudekDPretreatment with prasugrel in non-ST-segment elevation acute coronary syndromesN Engl J Med201336911999101023991622